Bionomics Limited

ASX:BNO Lagerbericht

Marktkapitalisierung: AU$14.7m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Bionomics Management

Management Kriterienprüfungen 0/4

We currently do not have sufficient information about the CEO.

Wichtige Informationen

Spyros Papapetropoulos

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehaltsn/a
Amtszeit als Geschäftsführerless than a year
Eigentum des Geschäftsführersn/a
Durchschnittliche Amtszeit des Managementsless than a year
Durchschnittliche Amtszeit der Vorstandsmitglieder3yrs

Jüngste Management Updates

Recent updates

Is Bionomics (ASX:BNO) In A Good Position To Deliver On Growth Plans?

Jun 14
Is Bionomics (ASX:BNO) In A Good Position To Deliver On Growth Plans?

Is Bionomics (ASX:BNO) In A Good Position To Invest In Growth?

Feb 23
Is Bionomics (ASX:BNO) In A Good Position To Invest In Growth?

Is Bionomics (ASX:BNO) In A Good Position To Deliver On Growth Plans?

Sep 14
Is Bionomics (ASX:BNO) In A Good Position To Deliver On Growth Plans?

Companies Like Bionomics (ASX:BNO) Are In A Position To Invest In Growth

Nov 15
Companies Like Bionomics (ASX:BNO) Are In A Position To Invest In Growth

Did You Miss Bionomics' (ASX:BNO) 86% Share Price Gain?

Dec 30
Did You Miss Bionomics' (ASX:BNO) 86% Share Price Gain?

Geschäftsführer

Spyros Papapetropoulos (50 yo)

less than a year

Amtszeit

Dr. Spyridon Papapetropoulos, M. D., Ph. D., also known as Spyros, serves as Director, President & Chief Executive Officer at Bionomics Limited from January 05, 2023. He serves as Member of Scientific Advi...

Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Adrian Hinton
Financial Controllerless than a yearAU$323.78k0.0048%
A$ 700.6
Spyridon Papapetropoulos
CEO, President & Directorless than a yearkeine Datenkeine Daten
Timothy Cunningham
Chief Financial Officerless than a yearkeine Datenkeine Daten
Paul Rolan
Consultant Chief Medical Officer of Clinical Neuroscienceno dataAU$102.00kkeine Daten
Julie Kerner
Senior Vice President of Business Operationsless than a yearkeine Datenkeine Daten
Atul Mahableshwarkar
Acting Chief Medical Officerless than a yearkeine Datenkeine Daten
Suzanne Irwin
Company Secretary2.3yrskeine Datenkeine Daten

0.3yrs

Durchschnittliche Betriebszugehörigkeit

60yo

Durchschnittliches Alter

Erfahrenes Management: BNO's management team is not considered experienced ( 0.3 years average tenure), which suggests a new team.

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Spyridon Papapetropoulos
CEO, President & Directorless than a yearkeine Datenkeine Daten
Errol B. De Souza
Non-Executive Director15.5yrsAU$4.03m0.025%
A$ 3.7k
David Wilson
Independent Non-Executive Director7.2yrsAU$87.00k0.017%
A$ 2.5k
Alan Fisher
Independent Non-Executive Chair of the Board6.9yrsAU$87.00k0.0068%
A$ 1.0k
Jane Ryan
Independent Non-Executive Director2.8yrsAU$93.15k0%
A$ 0
Srinivas Rao
Member of Clinical Advisory Board1.8yrsAU$57.75kkeine Daten
Murray Stein
Member of Clinical Advisory Boardno datakeine Datenkeine Daten
Steven Williams
Scientific Advisorno datakeine Datenkeine Daten
Allan Young
Scientific Advisorno datakeine Datenkeine Daten
Marina Picciotto
Scientific Advisorno datakeine Datenkeine Daten
Peter Miles Davies
Independent Non-Executive Director2.1yrsAU$77.00k0.018%
A$ 2.7k
Aaron N. Weaver
Independent Non-Executive Nominee Director3.1yrsAU$77.00kkeine Daten

3.0yrs

Durchschnittliche Betriebszugehörigkeit

56.5yo

Durchschnittliches Alter

Erfahrener Vorstand: BNO's board of directors are not considered experienced ( 3 years average tenure), which suggests a new board.